Cumlaude Lab, one of Spain's leading gynaecological care brands, has announced in a press release its foray into the international market, marking a significant milestone in its business trajectory. The brand's strategic decision to expand into international markets has resulted in remarkable growth outside Spain.
With a clear vision and meticulous strategy, the brand has established a strong presence in 26 countries in three years, culminating in its inaugural sponsorship of the FIGO (International Federation of Gynecology and Obstetrics) World Congress of Gynecology in Paris last month (Oct 9-12 2023). This milestone has a very important significance for the brand and reflects its significant impact and prominent presence in the global women's health arena worldwide. The brand that is leading the development of the Gynaecological Health Category in Spanish pharmacy exports its expertise and innovation to improve the quality of life of women around the world.
Its international expansion is mainly focused on Latin America and the Maghreb, but its greatest success is in China. In such a dynamic and competitive market, Cumlaude Lab has quickly gained ground, standing out for the quality and innovation of its intimate care products. Jennifer Verhelle, Brand Director, presided over the opening ceremony of FIGO and stated: "We are thrilled by the response we have received in Spain and abroad and are committed to continuing to offer the highest quality intimate health products to contribute to the wellbeing of women globally. And of course, Cumlaude Lab accompanies gynaecologists around the world and offers them solutions to improve the quality of life of their patients at every stage of their lives."
This sponsorship marks the beginning of an exciting new phase for Cumlaude Lab. With a solid foundation in place, the company will continue to explore new opportunities and markets to maintain and enhance its leadership.